Loading insider details...
Beta
Latest Form 4 (Apr 9, 2026): Grant/Award of 17,578 OVID shares, $45.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 9, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 17,578 | $45.0K |
| Mar 6, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Sale | 29 | $9.3K |
| Mar 5, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,688 | n/a |
| Mar 2, 2026 | Ovid Therapeutics Inc. (OVID) | Grant/Award | 65,000 | n/a |
| Feb 25, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 158 | n/a |
| Feb 18, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 4,000 | n/a |
| Jan 14, 2026 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 3,800 | n/a |
| Nov 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Exercise/Conversion | 8,161 | $972.2K |
| Oct 3, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 2,102 | n/a |
| Aug 19, 2025 | ALNYLAM PHARMACEUTICALS, INC. (ALNY) | Grant/Award | 2,851 | n/a |